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Schlader ZJ, Rivas E, Soller BR, Convertino VA, Crandall CG.
Tissue oxygen saturation during hyperthermic progressive central hypovole-
mia. Am J Physiol Regul Integr Comp Physiol 307: R731–R736, 2014. First
published July 16, 2014; doi:10.1152/ajpregu.00190.2014.—During nor-
mothermia, a reduction in near-infrared spectroscopy (NIRS)-derived
tissue oxygen saturation (SO2) is an indicator of central hypovolemia.
Hyperthermia increases skin blood flow and reduces tolerance to
central hypovolemia, both of which may alter the interpretation of
tissue SO2 during central hypovolemia. This study tested the hypoth-
esis that maximal reductions in tissue SO2 would be similar throughout
normothermic and hyperthermic central hypovolemia to presyncope.
Ten healthy males (means  SD; 32  5 yr) underwent central
hypovolemia via progressive lower-body negative pressure (LBNP) to
presyncope during normothermia (skin temperature 34°C) and hy-
perthermia (1.2  0.1°C increase in internal temperature via a
water-perfused suit, skin temperature 39°C). NIRS-derived forearm
(flexor digitorum profundus) tissue SO2 was measured throughout and
analyzed as the absolute change from pre-LBNP. Hyperthermia re-
duced (P  0.001) LBNP tolerance by 49  33% (from 16.7  7.9
to 7.2  3.9 min). Pre-LBNP, tissue SO2 was similar (P  0.654)
between normothermia (74  5%) and hyperthermia (73  7%).
Tissue SO2 decreased (P  0.001) throughout LBNP, but the reduc-
tion from pre-LBNP to presyncope was greater during normothermia
(10  6%) than during hyperthermia (6  5%; P  0.041).
Contrary to our hypothesis, these findings indicate that hyperthermia
is associated with a smaller maximal reduction in tissue SO2 during
central hypovolemia to presyncope.
lower body negative pressure; heat stress; simulated hemorrhage;
syncope
HEMORRHAGE, AND SUBSEQUENT cardiovascular decompensation,
is a leading cause of death in both civilian and military settings
(3, 14). That said, up to 25% of battlefield deaths are poten-
tially survivable if adequate detection, intervention, and treat-
ment is provided, with 85% of those being hemorrhage-
related (8, 16). Surviving a hemorrhagic injury is extremely
time-sensitive (3). Thus, early recognition of the severity of the
injury and rapid medical intervention is vital to patient survival
(17). Unfortunately, changes in traditional hemodynamic
markers (e.g., blood pressure and heart rate) during a hemor-
rhagic event are often late indicators of cardiovascular insta-
bility and are, therefore, poor survival prognosticators (5).
Interestingly, Soller et al. (21, 22) identified that tissue oxygen
saturation (SO2), in the region of skeletal muscle, determined
noninvasively via near-infrared spectroscopy (NIRS), is re-
duced during the initial stages of graded lower body negative
pressure (LBNP), a hemorrhage model (11). In the absence of
changes in metabolism, when blood flow under the measure-
ment area is reduced, an increase in oxygen extraction ensues
that is reflected in proportional reductions in tissue SO2 (2).
Thus, reductions in tissue SO2 during LBNP reflect the mag-
nitude of reductions in muscle blood flow in the measurement
area (21, 22). Importantly, these LBNP-induced reductions in
tissue SO2 occur prior to changes in blood pressure and heart
rate and reflect the onset and the magnitude of reductions in
stroke volume (21, 22). This is notable given that stroke
volume is an index of the degree of central hypovolemia, but it
is challenging to accurately measure in the field. Thus, nonin-
vasive monitoring of tissue SO2 appears to be an early indicator
of central hypovolemia in humans, suggesting it may be a
valuable tool for monitoring the severity of blood loss during
a hemorrhagic injury in prehospital and/or field settings.
Hyperthermia (i.e., increases in internal and skin tempera-
tures) universally decreases tolerance to a simulated hemor-
rhagic insult (19), suggesting that the timeline to begin treat-
ment is shortened during such conditions. Notably, early,
noninvasive indicators of central hypovolemia during hyper-
thermia have not been determined. Therefore, the objective of
this study was to test the hypothesis that, relative to that
occurring during normothermia, hyperthermia will not affect
the magnitude of maximal reductions in tissue SO2 occurring
during LBNP to presyncope. The testing of this hypothesis will
provide data regarding the utility of tissue SO2 as an early
indicator of the severity of hemorrhage-induced central hypo-
volemia while hyperthermic. Such information could dictate
medical treatment decisions made in prehospital and/or field
settings. These findings have implications for conditions in
which individuals are often hyperthermic and at an increased
risk of a hemorrhagic injury (e.g., soldiers, miners, and fire-
fighters).
METHODS
Subjects. Ten healthy, physically active, males participated in this
study. The subject characteristics were (means  SD) the following:
age, 32  5 yr; height, 183  9 cm; and weight, 85.1  12.5 kg. All
subjects were nonsmokers, not taking medications, and were free of
any known cardiovascular, metabolic, neurological, or psychological
diseases. Each subject was fully informed of the experimental proce-
dures and possible risks before giving informed, written consent. This
protocol and informed consent were approved by the Institutional
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Review Boards at the University of Texas Southwestern Medical
Center at Dallas and Texas Health Presbyterian Hospital of Dallas,
and all procedures conformed to the standards set by the Declaration
of Helsinki. Subjects arrived at the laboratory euhydrated (confirmed
via a urine-specific gravity 1.025) and having refrained from stren-
uous exercise, alcohol, and caffeine for a period of 24 h. Testing was
completed in the northern hemisphere (Dallas, Texas) during fall,
winter, and spring months.
Instrumentation and measurements. Approximately 60 min prior to
experimental testing, each subject swallowed a telemetry pill (HQ,
Palmetto, FL) for the measurement of intestinal temperature. Mean
skin temperature was measured as the weighted average of six
thermocouples attached to the skin. Body temperature was controlled
via a water-perfused tube-lined suit (Med-Eng, Ottawa, ON, Canada)
that covered the entire body except the head, hands, one forearm, and
the feet. Heart rate was continually recorded from an electrocardio-
gram (HP Patient Monitor, Agilent, Santa Clara, CA) interfaced with
a cardiotachometer (CWE, Ardmore, PA). Beat-to-beat blood pressure
was continuously measured via the Penaz method (Finometer Pro,
FMS, Amsterdam, The Netherlands), which was confirmed intermit-
tently via auscultation of the brachial artery by electrosphygmoma-
nometry (Tango, SunTech, Raleigh, NC). Tissue SO2 was measured
noninvasively using NIRS (CareGuide 1100, Reflectance Medical,
Westborough, MA). This NIRS device uses a novel sensor design and
mathematical preprocessing techniques to correct spectra for varia-
tions in skin pigment and fat prior to the calculation of tissue SO2 (9).
The NIRS sensor was placed on the left forearm over the flexor
digitorum profundus in the longitudinal axis with the head of the
sensor nearest to the olecranon process and secured against the skin
with custom adhesive pads.
Experimental protocol. Subjects visited the laboratory on two
separate occasions, separated by at least 8 wk, but completed at the
same time of day (within a subject). During both trials, following
instrumentation, subjects rested quietly in the supine position for at
least 45 min, while normothermic water (34°C) perfused the suit.
After baseline data collection, subjects underwent either whole body
passive heat stress or a normothermic time control period, the latter of
which was 40–60 min in duration. Whole body passive heat stress
was induced by perfusing 49°C water through the suit that was
sufficient to increase internal temperature 1.2°C above baseline,
while 34°C water was perfused through the suit throughout the
normothermic, time control trial. The subjects were not allowed to
drink fluids at any time during either trial. Both trials were conducted
in a randomized, counterbalanced manner. Immediately following the
heating/time control period, the subjects underwent progressive LBNP
to presyncope. LBNP commenced at 20 mmHg, with the level of
LBNP increasing by 10 mmHg every 3 min until the onset of syncopal
signs and symptoms: continued self-reporting of feeling faint, sus-
tained nausea, rapid and progressive decreases in blood pressure,
resulting in sustained systolic blood pressure being 80 mmHg,
and/or relative bradycardia accompanied with a narrowing of pulse
pressure. Notably, every LBNP trial was terminated due to hemody-
namically identified syncopal signs.
Data and statistical analyses. Most data were collected at 50 Hz via
a data acquisition system (Biopac System, Santa Barbara, CA), the
exception being the NIRS tissue SO2 data, which were sampled every
30 s. Steady-state data (3-min average) were analyzed at baseline (i.e.,
prethermal perturbation) and just prior to commencing LBNP (i.e.,
postthermal perturbation or time control period; Pre-LBNP). During
LBNP, data (2-min average) were statistically compared between
thermal conditions at 20 mmHg LBNP (n  10), 30 mmHg LBNP
(n 9, due to poor NIRS signal in one subject), and 40 mmHg LBNP
(n 5, due to presyncope occurring at 30 mmHg during hyperthermia
in an additional four subjects). Data were also analyzed at presyncope
in both trials, regardless of the LBNP stage (1-min average; presyn-
cope; n  9) and at the same level of normothermia LBNP as that
occurring at hyperthermia presyncope (mean LBNP level: 40  10
mmHg; n 9), i.e., the highest common LBNP stage between thermal
conditions for each subject. Muscle metabolism changes minimally
during hyperthermia under resting conditions (18), and therefore,
changes in NIRS tissue SO2 reflect the magnitude and direction of
changes in tissue perfusion (2). Since perfusion through a vascular bed
is governed, in part, by perfusion pressure, an index of tissue vascular
conductance (tVC) was calculated as the quotient of tissue SO2 and
mean arterial pressure. To evaluate the isolated effect of LBNP, both
with and without hyperthermia, data were also analyzed as the change
from Pre-LBNP.
Baseline, Pre-LBNP, and during LBNP (20–40 mmHg LBNP)
data were analyzed using two-way (main effects: trial 	 time)
repeated-measures ANOVA. Data at normothermia presyncope, hy-
perthermia presyncope, and normothermia 40  10 mmHg LBNP
(i.e., the same normothermia LBNP as that occurring at hyperthermia
presyncope) were analyzed using one-way repeated-measures ANOVA.
Where appropriate, post hoc Holm-Sidak pair-wise comparisons were
made. Data were analyzed using SigmaPlot (v.12, Systat Software,
Chicago, IL) with a priori statistical significance set at P  0.05. All
data are reported as means  SD.
RESULTS
Responses to hyperthermia alone. Baseline internal and
mean skin temperatures were not different (P  0.498) be-
tween trials (Table 1). Whole body passive heat stress in-
creased (P  0.001) both intestinal and mean skin tempera-
tures by 1.2  0.1°C and 5.1  0.1°C, respectively, whereas
temperatures remained unchanged throughout the normother-
mia trial (0.0  0.2°C and 0.0  0.7°C, P  0.217). Mean
arterial pressure slightly increased (P  0.013) from baseline
to Pre-LBNP during the normothermia trial, but was un-
changed (P  0.097) during the hyperthermia trial (Table 1).
Tissue SO2 increased (P  0.009) from baseline to Pre-LBNP
in both trials (Table 1), while the magnitude of this increase
was not different (P  0.593) between trials. During normo-
thermia, tVC did not change (P  0.994) from baseline to
Table 1. Thermal and hemodynamic responses from baseline to Pre-LBNP during the normothermia and hyperthermia trials
Normothermia Hyperthermia
Baseline Pre-LBNP Baseline Pre-LBNP
Intestinal temperature, °C 37.0  0.2 37.0  0.3 36.9  0.1 38.1 0.1*†
Mean skin temperature, °C 34.1  0.5 34.2  0.7 34.0  0.3 39.1 0.7*†
Heart rate, bpm 58  8 62  9 59  8 99 16*†
Mean arterial pressure, mmHg 82  6 87  8† 80  7 77 6
Tissue SO2, % 70  4 74  5† 68  4 73 7†
tVC (%/mmHg) 0.86  0.07 0.86  0.11 0.86  0.10 0.95 0.11†#
Tissue SO2, near infrared spectroscopy-derived tissue oxygen saturation; tVC, tissue vascular conductance. *Significantly different from normothermia (P 
0.001). †Significantly different from baseline (P  0.047). #Significantly different from normothermia (P  0.054).
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Pre-LBNP, but increased (P 0.047) during this period during
hyperthermia.
Responses to hyperthermic LBNP. LBNP time to tolerance
(normothermia: 16.7  7.9 min; hyperthermia: 7.2  3.9 min)
and the final LBNP stage reached (normothermia: 70  20
mmHg; hyperthermia: 40  10 mmHg) were higher (P 
0.001) during the normothermia trial. During hyperthermia,
mean arterial pressure decreased (P  0.001) during 20 through
40 mmHg LBNP, but not at these LBNP stages during normo-
thermia (Fig. 1). Absolute mean arterial pressure and reduc-
tions (relative to Pre-LBNP) in mean arterial pressure at
presyncope were not different (P  0.121) between thermal
conditions (Fig. 1). However, mean arterial pressure at normo-
thermia 40  10 mmHg LBNP was higher (P  0.007) than
this value when subjects were at presyncope during both
normothermia and hyperthermia (Fig. 1). Heart rate was
30–40 bpm higher (P  0.001) throughout hyperthermia prior
to LBNP and increased (P 0.001) during LBNP in both trials
(change from Pre-LBNP to presyncope: normothermia:38
32 bpm; hyperthermia: 27  20 bpm). In both trials, tissue
SO2 progressively decreased (P  0.001) throughout LBNP
(Fig. 2). However, the magnitude of this reduction was greater
(P  0.041) at presyncope during normothermia (10  6%)
than during hyperthermia (6  5%) (Fig. 2). At 40  10
mmHg LBNP, the reduction in tissue SO2 was not different
(P  0.803) between trials, despite this being the average
LBNP level at which presyncope occurred during hyperther-
mia, while tissue SO2 continued to further decrease (P 0.028)
through presyncope in the normothermic trial (Fig. 2).
Throughout LBNP, tVC was higher (P  0.042) during hy-
perthermia than during normothermia, and this persisted
through presyncope (Fig. 3).
DISCUSSION
The primary objective of this study was to test the hypoth-
esis that hyperthermia would not affect changes in tissue SO2
during LBNP to presyncope. Consistent with this hypothesis,
reductions in tissue SO2 were similar at each absolute level of
LBNP in both normothermia and hyperthermia (Fig. 2). Coun-
ter to our expectations, however, tissue SO2 was lower at
presyncope during normothermia compared with during hyper-
thermia (Fig. 2). Furthermore, hyperthermia, alone, increased
tissue SO2 independent of changes in blood pressure, as evi-
denced by an increase in tVC (Table 1). These findings indicate
that hyperthermia, alone, influences tissue SO2 under the mea-
surement area. Furthermore, these data also indicate that,
despite tissue SO2 being similar at absolute levels of LBNP
during both conditions, the magnitude of maximal reductions
in tissue SO2 were smaller at presyncope during hyperthermia,
compared with during normothermia. These data suggest that
tissue SO2 underestimates the relative magnitude of central
hypovolemia during hyperthermia.
Tissue SO2 during hyperthermia alone. In the absence of
changes in metabolic rate, changes in tissue SO2 indicate the
magnitude and direction of changes in tissue blood flow (2). In
the current study, tissue SO2 increased in a similar fashion in
both hyperthermic and normothermic conditions following
40–60 min of supine rest (Table 1). During normothermia,
increases in tissue SO2 were likely driven largely by increases
in tissue perfusion pressure rather than alterations in vascular
resistance, as indicated by elevated blood pressure without a
change in tVC (Table 1). By comparison, increases in tissue
SO2 during hyperthermia were likely the result of reduced
vascular resistance under the evaluated area rather than in-
creased tissue perfusion pressure, as indicated by an elevated
tVC in this thermal condition (Table 1). A possible explanation
for these findings is a large (upward to 6–10-fold) hyperther-
mia-induced increase in skin blood flow (4, 7). Increases in
muscle blood flow during hyperthermia may also contribute
(18), but this finding is not always observed (10). Furthermore,
a temperature-induced rightward shift in the oxygen dissocia-
tion curve cannot be discounted as a potential mechanism for
Fig. 1. Mean arterial pressure, expressed as absolute (top) and
the change (
) from pre-lower body negative pressure (Pre-
LBNP) (bottom), during normothermia and hyperthermia
(means  SD). On the left, data are presented from Pre-LBNP
through 40 mmHg LBNP, while data on the right data are
presented at presyncope during normothermia and hyperther-
mia and at the same level of normothermia LBNP as that
occurring at hyperthermia presyncope, within a given subject
(mean LBNP level: 40  10 mmHg). n indicates the number of
subjects included in the analysis at a given LBNP stage.
1Significantly different from Pre-LBNP for the indicated ther-
mal condition (P  0.005). *Significantly different from nor-
mothermia (P  0.006). ‡Significantly different from normo-
thermia presyncope (P  0.001). §Significantly different from
hyperthermia presyncope (P  0.007).
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hyperthermia-induced decreases in tissue SO2. However, any
influence of temperature on the oxygen dissociation curve is
likely small given the moderate level of hyperthermia in this
study (i.e., 1.2°C increase in intestinal temperature).
Tissue SO2 during hyperthermic LBNP. Tissue SO2 is as an
early indicator of the magnitude of central hypovolemia oc-
curring subsequent to simulated hemorrhage in normothermic
individuals (21, 22). Consistent with those observations, tissue
SO2 progressively decreased throughout LBNP in the normo-
thermic trial of the present study (Fig. 2). During hyperthermia,
tissue SO2 also decreased during LBNP, but at presyncope, the
magnitude of the maximal reduction was lower than that
occurring at presyncope during normothermia (Fig. 2). Inter-
estingly, at the highest common LBNP stage between trials
(i.e., 40  10 mmHg LBNP), despite this being the level of
LBNP that caused presyncope during the hyperthermic trial,
Fig. 2. Near infrared spectroscopy-derived tissue oxygen satu-
ration (tissue SO2), expressed as absolute (top) and the change
(
) from Pre-LBNP (bottom), during normothermia and hyper-
thermia (mean  SD). On the left, data are presented from
Pre-LBNP through 40 mmHg LBNP, while data on the right are
presented at presyncope during normothermia and hyperther-
mia and at the same level of normothermia LBNP as that
occurring at hyperthermia presyncope, within a given subject
(mean LBNP level: 40  10 mmHg). n indicates the number of
subjects included in the analysis at a given LBNP stage.
1Significantly different from Pre-LBNP for the indicated ther-
mal condition (P  0.030). ‡Significantly different from nor-
mothermia presyncope (P  0.041).
Fig. 3. Tissue vascular conductance (tVC), expressed as abso-
lute (top) and the change (
) from Pre-LBNP (bottom), during
normothermia and hyperthermia (means  SD). On the left,
data are presented from Pre-LBNP through 40 mmHg LBNP,
while data on the right data are presented at presyncope during
normothermia and hyperthermia and at the same level of
normothermia LBNP as that occurring at hyperthermia presyn-
cope, within a given subject (mean LBNP level: 40  10
mmHg). n indicates the number of subjects included in the
analysis at a given LBNP stage. 1Significantly different from
Pre-LBNP for the indicated thermal condition (P  0.004).
*Significantly different from normothermia (P  0.023). ‡Sig-
nificantly different from normothermia presyncope (P 
0.042). §Significantly different from hyperthermia presyncope
(P  0.011).
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the magnitude of the reduction in tissue SO2 was similar
between thermal conditions (Fig. 2). Given that at this point
during hyperthermia, blood pressure was profoundly lower
(Fig. 1) and the magnitude of central hypovolemia is greater
(6), it may be that the tissue SO2 underestimates the relative
magnitude of the central hypovolemic insult during hyperther-
mia. Furthermore, tVC was elevated throughout LBNP during
hyperthermia (Fig. 3), suggesting that, compared with that
occurring during normothermia, the vasculature under the
measurement area was in a dilated state. One explanation for
these observations may be due to hyperthermia-induced eleva-
tion in skin blood flow under the area of measurement (4, 7).
Attenuated reductions in muscle blood flow during hyperther-
mic LBNP may also contribute. This contention is supported
by evidence indicating that heated conduit blood vessels have
attenuated vasoconstrictor capacity in vitro (12, 13) but is
contrasted by in vivo evidence, indicating that muscle vaso-
constrictor capacity is preserved during leg heating (15). No-
tably, however, the extent by which hyperthermia impacts
muscle vasoconstrictor capacity currently remains unknown.
Clearly, further research is required to address the mecha-
nism(s) regarding the observed smaller reductions in tissue SO2
at presyncope during hyperthermia.
It is interesting to note that tVC increased during the latter
stages of LBNP in both trials (Fig. 3). These observations
corroborate other findings, indicating that muscle vasodilation
commonly precedes syncope (1). That this apparent vasodila-
tion occurred earlier during the hyperthermia trial (Fig. 3) can
likely be explained by the closer proximity of a given level of
LBNP to presyncope during the hyperthermia trial compared
with the normothermia trial. Although intriguing, it is impor-
tant to note that these findings should be interpreted with
caution, given that the utility of tVC as an indicator of tissue
vascular tone during LBNP and/or hyperthermia remains un-
certain.
Methodological considerations. It should be noted that the
findings presented herein are likely constrained to the NIRS
technology used in this study (i.e., CareGuide 1100, Reflec-
tance Medical) and may have been different had an alternative
NIRS technology been applied. Likewise, it is also notable that
the clinical applicability of this technology is in its infancy.
That said, although not directly related to the present study,
preliminary evaluation of this NIRS technology has found that
tissue SO2 is an indicator of plasma leakage in patients with
dengue hemorrhagic fever, highlighting tissue SO2’s potential
utility in a clinical setting (20).
Perspectives and Significance
Early recognition of the extent of a hemorrhagic injury and,
thus, timely treatment is vital to surviving such an insult (3, 17).
Noninvasive tissue SO2 has been proposed as a valuable tool for
monitoring the severity of central hypovolemia during the early
stages of a hemorrhagic injury in prehospital or field settings (21,
22). However, often those individuals who are at the highest risk
of a hemorrhagic injury are also hyperthermic (e.g., soldiers,
miners, and firefighters). Notably, the ability to tolerate a simu-
lated hemorrhagic event is markedly reduced during hyperthermia
(19), suggesting that the timeline to begin treatment is shortened
during such conditions. Therefore, the present study evaluated
whether LBNP-induced reductions in tissue SO2 were affected by
hyperthermia. It is clear that hyperthermia impacts tissue SO2
during progressive central hypovolemia. Specifically, tissue SO2
appears to underestimate the relative magnitude of the central
hypovolemic insult during hyperthermia. Thus, it remains un-
known whether a noninvasive measurement of tissue SO2 gener-
ated from the use of NIRS technology will provide the medic with
appropriate triage decision support regarding the severity of a
patient’s degree of central hypovolemia during hyperthermia.
Further research is required.
Conclusions. Compared with that occurring during normo-
thermia, the present study identified that reductions in tissue
SO2 during LBNP are similar with hyperthermia, but that
LBNP-induced maximal reductions in tissue SO2 are smaller at
presyncope in this thermal condition. These data suggest that
tissue SO2 underestimates the relative magnitude of central
hypovolemia during hyperthermia. These observations can be
explained by changes in muscle blood flow and/or hyperther-
mia-induced elevations in skin blood flow under the measure-
ment area. Further studies are needed to better understand the
application of NIRS-derived tissue SO2 as a noninvasive indi-
cator of central hypovolemia during hyperthermia.
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